Patient's Guide: China's Top 10 Dermatology Hospitals (2023 Fudan Rankings)
February 11, 2026
China's dermatology strengths and the top 10 dermatology hospitals per the 2023 Fudan rankings, with notable doctors and innovations.
China has rapidly ascended as a global leader in dermatology, combining cutting-edge research, advanced clinical treatments, and vast patient experience to establish itself among the top-tier nations in skin disease management. While Western countries (e.g., the U.S., Germany, and France) still dominate in rare genetic skin disorders and high-impact clinical trials, China excels in several key areas, making it a hub for dermatological innovation and large-scale patient care.
China's Key Strengths in Dermatology
- China's massive patient base (particularly for psoriasis, eczema, fungal infections, and skin cancer) allows dermatologists to accumulate unparalleled clinical experience.
- Hospitals like Huashan (Shanghai) and PUMCH (Beijing) see over 1 million annual dermatology visits, far exceeding most Western centers.
- This high throughput enables rapid refinement of diagnostic accuracy and treatment protocols.
- The National Natural Science Foundation of China (NSFC) and Ministry of Science and Technology heavily fund dermatology research, particularly in: biologics for psoriasis / atopic dermatitis (competing with Western-developed drugs like Dupixent); Traditional Chinese Medicine (TCM) integration (e.g., compound glycyrrhizin for eczema); AI-driven dermatology, where China is a global leader (e.g., Alibaba's AI melanoma detection, Tencent's dermatology telemedicine platforms).
- Key institutions (Fudan, Peking Union, Shanghai Jiao Tong) collaborate with Harvard, Johns Hopkins, and Karolinska Institute on skin cancer genomics and immunotherapy.
- China is the fastest-growing market for aesthetic dermatology, with innovations in: picosecond lasers (for pigmentation and tattoo removal); non-invasive skin tightening (HIFU, RF microneedling); stem cell-based therapies for scar revision.
- Due to uneven urban-rural healthcare distribution, China has pioneered AI teledermatology.
- West China Hospital leads in leprosy and fungal infection control in underserved regions.
Areas Where China Still Lags
- Rare skin diseases (e.g., epidermolysis bullosa) due to smaller patient pools.
- Pharmaceutical innovation (most biologics still originate from Western pharma).
- Global clinical trial leadership (most Phase III trials are U.S./EU-led).
2023 Fudan Top 10 Dermatology Hospitals
Huashan Hospital (Shanghai) — Reputation Score: 9.861. Asia's #1 for psoriasis and autoimmune blistering diseases. Key innovations: negative-pressure blister grafting for vitiligo (success rate >90%); AI-powered teledermatology platforms for rural outreach. Prof. Xu Xizhan: expert in skin lymphoma therapies.
Second-ranked hospital — Reputation Score: 8.750. Specialization: rare genetic skin disorders and leprosy eradication. Key doctors: Prof. Chen Hongguo, WHO advisor on leprosy and mycobacterial infections; Dr. Li Ming, pioneer in TCM-integrated therapies for eczema.
Third-ranked hospital — Reputation Score: 6.778. Strengths: cosmetic dermatology and laser therapies. Key innovations: picosecond laser technology for pigmentation disorders; stem cell-based scar revision treatments. Core team: Prof. Wang Lei, leading authority on laser dermatology.
Fourth-ranked hospital — Reputation Score: 6.630. Focus: cutaneous oncology and AI-assisted diagnostics. Key doctor: Prof. Li Hongfu, Director of the Skin Cancer Center.
Fifth-ranked hospital — Reputation Score: 5.472. Specialization: vitiligo and autoimmune diseases. Key innovation: tissue-engineered skin grafts for large-area vitiligo.
The remaining ranked hospitals:
- Rank 6: First Hospital of China Medical University (Shenyang) — score 5.343, notable focus on psoriasis clinical trials.
- Rank 7: Peking Union Medical College Hospital (PUMCH, Beijing) — score 3.380, notable focus on rare skin diseases.
- Rank 8: Ruijin Hospital, Shanghai Jiao Tong University (Shanghai) — score 3.056, notable focus on melanoma immunotherapy.
- Rank 9: Shandong Provincial Hospital of Skin Diseases (Jinan) — score 2.241, notable focus on fungal infections.
- Rank 10: China-Japan Friendship Hospital (Beijing) — score 1.537, notable focus on allergic dermatitis.





